The objective of the proposed research is to gain a better understanding of the regulation of retroocular and endomysial connective tissue. Those tissues occupy an increased volume in the ophthalmopathy associated with Graves' disease and an accumulation of glycosaminoglycan in the retroocular space apparently accounts for the exophthalmos. We have found that hyaluronate synthesis is stimulated by interferon gamma in cultured retroocular and endomysial fibroblasts but not those derived from skin or breast adipose tissue. 1) We propose to characterize the stimulation by interferon gamma of hyaluronate synthesis in retroocular and endomysial fibroblasts. 2) We propose to study the effects of interferon gamma on the phosphorylation pattern of proteins in orbital fibroblast cultures. We will present preliminary data which suggest that the cytokine enhances phosphorylation of proteins in orbital fibroblast cultures but not in non-orbital cultures. We hypothesize that the stimulation of hyaluronate synthesis by interferon gamma is mediated through an activation of a kinase cascade. 3) We propose to determine whether lymphocytes cultured from individuals with Graves' ophthalmopathy produce increased amounts of interferon gamma. We hypothesize that if that cytokine has a role in the pathogenesis of Graves' ophthalmopathy, we may be able to detect increased interferon gamma production when compared to lymphocytes from individuals without Graves' disease. 4) We propose to determine whether a positive correlation exists between the serum concentration of interferon gamma and the clinical severity of Graves' ophthalmopathy. We present evidence that the serum concentration of that cytokine is elevated in some individuals with active Graves' disease.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY008976-02
Application #
2162608
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1992-12-01
Project End
1995-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Albany Medical College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Albany
State
NY
Country
United States
Zip Code
12208
Fernando, Roshini; Grisolia, Ana Beatriz Diniz; Lu, Yan et al. (2018) Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease. J Immunol 200:3942-3949
Smith, Terry J (2018) Challenges in Orphan Drug Development: Identification of Effective Therapy for Thyroid-Associated Ophthalmopathy. Annu Rev Pharmacol Toxicol :
Mohyi, Michelle; Smith, Terry J (2018) IGF1 receptor and thyroid-associated ophthalmopathy. J Mol Endocrinol 61:T29-T43
Lu, Yan; Atkins, Stephen J; Fernando, Roshini et al. (2018) CD34- Orbital Fibroblasts From Patients With Thyroid-Associated Ophthalmopathy Modulate TNF-? Expression in CD34+ Fibroblasts and Fibrocytes. Invest Ophthalmol Vis Sci 59:2615-2622
Smith, Terry J (2018) New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor. F1000Res 7:134
Smith, Terry J; Hegedüs, Laszlo (2017) Graves' Disease. N Engl J Med 376:185
Citterio, Cintia E; Veluswamy, Balaji; Morgan, Sarah J et al. (2017) De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone. J Biol Chem 292:15434-15444
Smith, Terry J; Kahaly, George J; Ezra, Daniel G et al. (2017) Teprotumumab for Thyroid-Associated Ophthalmopathy. N Engl J Med 376:1748-1761
Smith, Terry (2017) TSHR as a therapeutic target in Graves' disease. Expert Opin Ther Targets 21:427-432
Fernando, Roshini; Placzek, Ekaterina; Reese, Edmund A et al. (2017) Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy. J Clin Endocrinol Metab 102:776-785

Showing the most recent 10 out of 138 publications